(PharmaNewsWire.Com, November 03, 2017 ) In recent years, rising prevalence of sexually transmitted infections is continuously responsible for the growth of the contraceptive market. The percentage of women using contraceptives approaches has increased in both developed and developing countries. Researchers find that the campaigns that are generally undertaken by government agencies and NGOs are endorsed by celebrities, which is favoring the use of contraceptives among young adults. Considering these facts, a new study titled “Contraceptives Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” has been broadcasted to the vast repository of Market Research Hub (MRH). This 282-pages study offers precise knowledge about the active market regions as well as top players operating in this sector. Further, the report also offers predictions on market size, in terms of revenue (USD million) and growth rate during the forecast period from 2017-2025.
Contraception, also known as birth control or fertility control, refers to the use of methods or drugs or devices to prevent pregnancy as a consequence of sexual intercourse. Global contraceptives market is anticipated to grow speedily due to increasing public awareness in making right decisions about their sexual and reproductive health. As per the report findings, the global contraceptives market is likely to grow at a CAGR of 6.1% between 2017 and 2025. At this pace, the market to be evaluated at US$37,242.7 mn by the end of 2025 from its worth of US$22,050.0 mn in 2016.
In the initial section, the report talks about the precise market overview, including a market snapshot which provides information of various segments and sub-segments. The research then shifts focus towards the major dynamics, including drivers, trends, opportunities as well as restraints in the contraceptives market. For a clear understanding, the research highlights market for contraceptives in some of the prime regions including North America, Europe, Asia Pacific, Latin America, Middle East and Africa. In emerging regions, especially among the urban populace, modern education and career aspirations have been crucial factors for the increasing adoption of contraceptives. Of these, North America leads among other key regional markets with the region holding a share of 35.0% in 2016. The factors contributing to the growth of North America contraceptives market include rising prevalence of unintentional pregnancies, rising trend of delayed childbearing, and growing usage of contraceptives among teenagers.
Moving further, the report on global contraceptives market deeply analyzes the market on the basis of product type and distribution channel. Product type includes contraceptive drugs and contraceptive devices. The contraceptive drug is further segmented into oral contraceptive, contraceptive injectable, and topical contraceptive patch. Oral contraceptive is further segmented into combined contraceptives and mini-pills. Amongst the key product types, contraceptive devices hold dominance in terms of market share in 2016. Nevertheless, the segment of oral contraceptives within contraceptive drugs is anticipated to register the leading growth over the forecast period. On the other hand, based on distribution channel, contraceptives market is segmented into hospitals pharmacy, independent pharmacy, online platform, clinics and others.
Later, the report covers thorough competitive outlook that includes market share and profiles of chief players operating in the global market. Major players profiled in this report include Allergan plc, Mankind Pharma, Janssen Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mithra Pharmaceuticals, Cipla Inc., Bayer AG, HLL Lifecare Limited, Pfizer, Inc., Reckitt Benckiser Group Plc. and others.
Market Research Hub (MRH) is a next-generation reseller of medical equipments industry reports and analysis. MRH’s expansive collection of reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
